A point-of-care skin test for detecting latent tuberculosis infections (LTBI) -- developed by Serum Institute of India (SII) and Mylab Discovery Solutions -- was launched on Monday at a cost the ...

Harvard Business Review Case Collection, one of the most prestigious institutes in the world, has included a case study on Mylab’s journey and its path-breaking innovations in the face of adversities.

Mylab and Serum Institute of India have launched Nasovac S4, India's first needle-free nasal influenza vaccine. The vaccine contains four influenza virus strains and is recommended for individuals ...